Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Orexin receptor type 2 | ||
Ligand | BDBM386116 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Measurement of Orexin Type 2 Receptor Agonist Activity | ||
EC50 | 2300±n/a nM | ||
Citation | Fujimoto, T; Rikimaru, K; Fukuda, K; Sugimoto, H; Matsumoto, T Substituted piperidine compound and use thereof US Patent US10508083 Publication Date 12/17/2019 | ||
More Info.: | Get all data from this article, Assay Method | ||
Orexin receptor type 2 | |||
Name: | Orexin receptor type 2 | ||
Synonyms: | HCRTR2 | Hypocretin receptor type 2 | OX2R_HUMAN | Orexin receptor type 2 (OR 2) | Orexin receptor type 2 (OR-2) | Orexin receptor type 2 (OX2) | Orexin receptor type 2 (OX2R) | Orexin receptor type 2 (OxR2) | Ox-2-R | Ox2-R | ||
Type: | Protein | ||
Mol. Mass.: | 50710.53 | ||
Organism: | Homo sapiens (Human) | ||
Description: | O43614 | ||
Residue: | 444 | ||
Sequence: |
| ||
BDBM386116 | |||
n/a | |||
Name | BDBM386116 | ||
Synonyms: | N-(cis-1-(cyclopropylsulfonyl)-2-(((cis- 4-isopropylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide | US10287305, Example 62 | US10508083, Example 62 | US11292766, Example 62 | ||
Type | Small organic molecule | ||
Emp. Form. | C19H36N2O5S2 | ||
Mol. Mass. | 436.63 | ||
SMILES | CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1S(=O)(=O)C1CC1)NS(C)(=O)=O |r,wU:3.2,6.9,11.11,12.25,(-6,2.85,;-4.67,3.62,;-4.67,5.16,;-3.33,2.85,;-3.33,1.31,;-2,.54,;-.67,1.31,;-.67,2.85,;-2,3.62,;.67,.54,;.67,-1,;2,-1.77,;3.33,-1,;4.67,-1.77,;4.67,-3.31,;3.33,-4.08,;2,-3.31,;.67,-4.08,;-.42,-5.16,;1.76,-5.16,;-.67,-3.31,;-1.44,-1.97,;-2.21,-3.31,;3.33,.54,;4.67,1.31,;6,.54,;3.9,2.65,;5.44,2.65,)| | ||
Structure |